nervous system
• increased apoptosis in corpus callosum and cortical region at age 12 and 20 weeks as indicated by TUNEL assay
• normal in corpus callosum and cortical region at age 4 weeks as indicated by TUNEL assay
|
• increased apoptosis in cortical region at age 12 and 20 weeks as indicated by TUNEL assay
• normal in cortical region at age 4 weeks as indicated by TUNEL assay
|
• 7% reduction of volume at age 20 and 12% at age 30 weeks
|
• significant reduction in expression of mature oligodendrocyte markers Cnp and Mbp from age 12 weeks
• normal expression of pre-oligodendrocyte marker Pdgfra at age 12 weeks
|
• significant reduction in expression of early neuronal marker Tubb3 in cortical region and hippocampus at age 5 months
• thin neuronal fibers with differentiated neurons after 1 week in culture
|
• significant reduction in expression of differentiation marker Map2 at age 4, 12 and 20 weeks
|
• significant reduction in expression of early neuronal marker Tubb3 in cortical region and hippocampus at age 5 months
|
• significant reduction in expression of early neuronal marker Tubb3 in hippocampus at age 5 months
|
• significant increase in App and Syp expression from age 12 weeks
|
• increased axonal beading with differentiated neurons after 1 week in culture
|
behavior/neurological
• from age 10 weeks
|
• from age 10 weeks
|
• from age 10 weeks
|
cellular
• increased apoptosis in corpus callosum and cortical region at age 12 and 20 weeks as indicated by TUNEL assay
• normal in corpus callosum and cortical region at age 4 weeks as indicated by TUNEL assay
|
• increased apoptosis in cortical region at age 12 and 20 weeks as indicated by TUNEL assay
• normal in cortical region at age 4 weeks as indicated by TUNEL assay
|
• significant reduction in expression of differentiation marker Map2 at age 4, 12 and 20 weeks
|
growth/size/body
• from age 10 weeks; 35% reduction at age 40 weeks
|
weight loss
(
J:296329
)
• from age 10 weeks; 40% reduction at age 40 weeks
|
mortality/aging
homeostasis/metabolism
• normal proline, glutamate, gamma-aminobutyric acid (GABA) and serine metabolis
• normal circulating glycine levels
• significant increase in brain glycine levels
|
skeleton